MacroGenics (MGNX) announced that effective as of August 13, Eric Risser has been appointed president, CEO and to the board of directors. Risser has served as COO at MacroGenics since 2022. Risser succeeds Scott Koenig, who is stepping down after serving as president and CEO for the past 24 years.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGNX:
- MGNX Earnings this Week: How Will it Perform?
- MacroGenics’ Prostate Cancer Study: A Potential Game-Changer?
- MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
- MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
- MacroGenics Advances Cancer Treatment with MGC026 Study Update